AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 91 min read$MDT

KIIL HARRY SKIP sold $337K of MDT

KIIL HARRY SKIP (EVP & President Cardiovascular) sold 4,189 shares of Medtronic plc (MDT) at an average of $80.44 ($80.44–$80.45, $0.34M total) across 2 trades on 2026-06-08.

Original reporting
SEC EDGAR · KIIL HARRY SKIP
Published Jun 9, 2026, 8:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 9, 2026, 8:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$MDT
Neutral
medium confidence
Mentioned
$MDT
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MDTNeutralLow
01

Why it matters

Traders may monitor for follow-on insider activity or correlate with any concurrent company-specific catalysts, but this filing alone does not provide new operational or financial guidance.

02

Market read

A primary-source insider sale disclosure for MDT; sentiment impact is likely limited absent other negative news.

03

What to watch

Insider sales can be driven by diversification, tax planning, or pre-existing personal liquidity needs; without additional context, directional inference is weak.

Relevance 4/10Novelty 6/10Timing: Filed 2026-06-09; sale executed 2026-06-08

Background

The article is an SEC Form 4 insider transaction disclosure from Medtronic plc, reporting an open-market sale by a cardiovascular business executive.

Company-level read

Ticker impact

$MDTNeutralMedium confidence
Context

Medtronic insider KIIL HARRY SKIP (EVP & President, Cardiovascular) sold 4,189 shares in open-market transactions on 2026-06-08.

Expected impact

Low likelihood of a sustained price move; any impact is likely short-lived unless accompanied by other negative company news.

Evidence & confidence

The filing is a primary-source insider transaction, but it is not tied to a 10b5-1 plan and is not large enough (relative to MDT) to imply a fundamental change by itself.

Market effects

Sector

Minimal—single-company insider sale without accompanying operational/regulatory updates.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because the sale is not explicitly tied to a 10b5-1 plan, some traders may interpret it as a more meaningful near-term caution signal than typical routine selling.

Key entities

  • issuer
    Medtronic plc

    MDT, the company whose shares were sold by an executive insider.

  • insider
    KIIL HARRY SKIP

    EVP & President, Cardiovascular; reported open-market sale of 4,189 shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

MDT insider trading history →

Related articles

SEP 17
$MDTHighAI 8/10

Medtronic Advances Diabetes Spin

Medtronic (MDT) launched an exchange offer for up to 225,361,295 MiniMed Group Inc. shares, part of its diabetes business separation. It corrected a prospectus error regarding the guaranteed delivery period for tender documentation, which now expires at 5:00 p.m. NY time on the second NYSE trading day after execution.

tipranks.com1 min
SEP 17
$MDTHighAI 9/10

[SC TO-I/A] Medtronic plc Amended Issuer Tender Offer

Medtronic plc amended its tender offer to exchange up to 225,361,295 shares of MiniMed Group, Inc. common stock for its own shares, with a potential increase of 27,452,053 shares if oversubscribed. The offer, filed with the SEC, aims to exchange approximately 80.1% of MiniMed's outstanding shares. MiniMed has also filed a registration statement for the new shares.

stocktitan.net2 min
SEP 17
$MDTMed

Medtronic plc (MDT): Other Events

Medtronic plc (MDT) filed an SEC Form 8-K — Other Events. Item 8.01. Other Events On September 14, 2026, Medtronic plc, a public limited company organized under the laws of Ireland (“Medtronic”), commenced an offer to exchange (the “Exchange Offer”) up to 225,361,295 newly issued shares of common stock, par value $0.01 per share (“MiniM

SEC EDGAR 8-K2 min
SEP 17
$MDTHighAI 8/10

Should You Buy Medtronic Stock as Its Hugo Surgical Robot Gains Ground?

Medtronic (MDT) shares are down 3% this year, but the company's Hugo robotic-assisted surgery system is gaining market share. The FDA approved Hugo for urological procedures, and Medtronic submitted new filings for broader use. Q1 2027 revenue was $9.8B, up 13.7% YoY, with EPS of $1.14, up 40.7%. The company raised full-year guidance and is on track to become a Dividend King. Medtronic's dividend yield is 3.06%, and it is expanding in cardiac and spinal technologies.

fool.com3 min
SEP 17
$MDTMed

Medtronic Sees AI, Ablation and Targeted M&A Fueling Growth

Medtronic (MDT) reported Q1 growth of 7% (excluding an extra week), driven by innovations in cardiac ablation, renal denervation, robotics, and pelvic health. Cardiac ablation revenue surpassed $2B, while pelvic health revenue grew 15%. The company is investing in robotics, structural heart, and neuroscience, and plans to focus on tuck-in acquisitions. Medtronic expects to discuss its growth outlook further at an upcoming Investor Day.

yahoo.com3 min